HAVN Life Sciences Inc.
HAVLF
$0.001
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.50K | 6.30K | 87.70K | 823.70K | 663.70K |
| Total Receivables | 220.20K | 376.80K | 50.50K | 249.10K | 682.40K |
| Inventory | 790.30K | 767.70K | -- | 896.60K | 852.10K |
| Prepaid Expenses | 11.30K | 30.30K | 18.50K | 172.60K | 201.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.03M | 1.18M | 156.70K | 2.14M | 2.40M |
|
|
|||||
| Total Current Assets | 1.03M | 1.18M | 156.70K | 2.14M | 2.40M |
| Net Property, Plant & Equipment | 1.20K | 1.20K | 0.00 | 278.10K | 413.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 0.00 | 0.00 | 728.80K | 7.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 18.50K | 18.60K |
| Total Assets | 1.03M | 1.18M | 156.70K | 3.17M | 10.58M |
|
|
|||||
| Total Accounts Payable | 349.70K | 231.60K | 327.80K | 250.80K | 242.80K |
| Total Accrued Expenses | 35.90K | 35.10K | 89.70K | 162.00K | 110.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 438.40K | 61.80K | 102.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 43.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 43.00K |
| Total Current Liabilities | 385.60K | 266.70K | 855.90K | 474.60K | 499.10K |
|
|
|||||
| Total Current Liabilities | 385.60K | 266.70K | 855.90K | 474.60K | 499.10K |
| Long-Term Debt | 19.70K | 227.30K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 242.00K | 216.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 405.20K | 494.10K | 855.90K | 716.60K | 716.00K |
|
|
|||||
| Common Stock & APIC | 38.71M | 37.48M | -- | 38.80M | 36.94M |
| Retained Earnings | -42.90M | -41.44M | -699.20K | -41.25M | -32.60M |
| Treasury Stock & Other | 4.81M | 4.65M | -- | 4.90M | 5.53M |
| Total Common Equity | 628.20K | 688.30K | -699.20K | 2.45M | 9.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 628.20K | 688.30K | -699.20K | 2.45M | 9.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 628.20K | 688.30K | -699.20K | 2.45M | 9.87M |
|
|
|||||